| خلاصه مقاله | Introduction:
Androgenetic alopecia (AGA) is caused by miniaturization of androgen-sensitive hair follicles
and common form of scalp hair loss. Finasteride and Minoxidil have been approved by the
American Food and Drug Administration (FDA) for the treatment of AGA. But these have a lot
of side effects. Herbal extracts have more mechanism for treating AGA, fewer side effects and
patient satisfaction.
The aim of this study was to examine the efficacy and safety of topical herbal solution in males
with AGA.
Materials & Methods:
We conducted a randomized, double-blind, parallel-group clinical trial at the dermatology
department in Sina hospital. Male volunteers aged between 18 and 50 years with mild to
moderate AGA were randomly assigned (1:1), via computer-generated randomization, to
receive either herbal or Minoxidil5% topical solution. The first group received herbal solution
every evening + Minoxidil 5% every morning for 12 to 24 weeks, while the second group
received only Minoxidil 5% for the same period. After a baseline visit, patients were evaluated
by clinical examination, photographic documentation, a self-assessment test, and measuring
hair diameter every month. Written informed consent was obtained from all participants prior
to entry.
Results:
Analysis of the two groups showed significant differences and highly positive response to
treatment in the first group compared to the second group. In the first group, hair diameter
increased compared to the baseline visit. Specifically, after a few weeks, hair loss was stopped
only in the first group. The patients were satisfied with the herbal solution and during this
period, no significant adverse events were reported
Conclusion:
These results suggest that the new herbal solution is responsible for a significant improvement of
AGA and could be an alternative treatment in patients who didn’t have an efficiency of standard
medications or cannot tolerate those side-effects. To our knowledge, this herbal solution for the
first time covers all three major causes of AGA, including the 5α-reductase enzyme, androgen
receptors, and paracrine agents that affecting dermal papilla. Therefore it acts with the triple
mechanism, different from the already existing therapies |